FDA NDC Directory · JSON-LD · Markdown

Zepbound

NDC 0002-2002 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nametirzepatide
Labeler / ManufacturerEli Lilly and Company
Marketing categoryNew Drug Application (innovator) · App NDA217806
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsTIRZEPATIDE (15 mg/.5mL)
Marketing started20240328
Package count2

External sources

Source: openFDA. Public-domain (CC0).